BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 16036105)

  • 21. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines.
    Sumita N; Bito T; Nakajima K; Nishigori C
    Exp Dermatol; 2006 Apr; 15(4):291-9. PubMed ID: 16512876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway.
    Wang SW; Hu J; Guo QH; Zhao Y; Cheng JJ; Zhang DS; Fei Q; Li J; Sun YM
    Oncol Rep; 2014 Nov; 32(5):1991-8. PubMed ID: 25216185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-cell contacts induce STAT3 activity in colon carcinoma cells through an autocrine stimulation loop.
    Tsareva SA; Wagner S; Müller A; Corvinus F; Friedrich K
    J Cancer Res Clin Oncol; 2011 May; 137(5):857-63. PubMed ID: 20830487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis.
    Heichler C; Scheibe K; Schmied A; Geppert CI; Schmid B; Wirtz S; Thoma OM; Kramer V; Waldner MJ; Büttner C; Farin HF; Pešić M; Knieling F; Merkel S; Grüneboom A; Gunzer M; Grützmann R; Rose-John S; Koralov SB; Kollias G; Vieth M; Hartmann A; Greten FR; Neurath MF; Neufert C
    Gut; 2020 Jul; 69(7):1269-1282. PubMed ID: 31685519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural small molecule bigelovin suppresses orthotopic colorectal tumor growth and inhibits colorectal cancer metastasis via IL6/STAT3 pathway.
    Li M; Yue GG; Song LH; Huang MB; Lee JK; Tsui SK; Fung KP; Tan NH; Lau CB
    Biochem Pharmacol; 2018 Apr; 150():191-201. PubMed ID: 29454618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HSP110 promotes colorectal cancer growth through STAT3 activation.
    Berthenet K; Bokhari A; Lagrange A; Marcion G; Boudesco C; Causse S; De Thonel A; Svrcek M; Goloudina AR; Dumont S; Hammann A; Biard DS; Demidov ON; Seigneuric R; Duval A; Collura A; Jego G; Garrido C
    Oncogene; 2017 Apr; 36(16):2328-2336. PubMed ID: 27819670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway.
    Zheng R; Ma J; Wang D; Dong W; Wang S; Liu T; Xie R; Liu L; Wang B; Cao H
    Mediators Inflamm; 2018; 2018():1562010. PubMed ID: 30498394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay.
    Fan X; Meng M; Li B; Chen H; Tan J; Xu K; Xiao S; Kwan HY; Liu Z; Su T
    J Transl Med; 2023 Apr; 21(1):260. PubMed ID: 37062842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRH promotes human colon cancer cell proliferation via IL-6/JAK2/STAT3 signaling pathway and VEGF-induced tumor angiogenesis.
    Fang X; Hong Y; Dai L; Qian Y; Zhu C; Wu B; Li S
    Mol Carcinog; 2017 Nov; 56(11):2434-2445. PubMed ID: 28618089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
    Ren C; Cheng X; Lu B; Yang G
    Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis.
    Chang YC; Su CY; Chen MH; Chen WS; Chen CL; Hsiao M
    Mol Cancer; 2017 Aug; 16(1):135. PubMed ID: 28784136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.
    Lin Q; Lai R; Chirieac LR; Li C; Thomazy VA; Grammatikakis I; Rassidakis GZ; Zhang W; Fujio Y; Kunisada K; Hamilton SR; Amin HM
    Am J Pathol; 2005 Oct; 167(4):969-80. PubMed ID: 16192633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
    Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review).
    Wang SW; Sun YM
    Int J Oncol; 2014 Apr; 44(4):1032-40. PubMed ID: 24430672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24.
    Yoshida M; Zhao L; Grigoryan G; Shim H; He P; Yun CC
    Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(8):G586-98. PubMed ID: 26867566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion.
    Lui GY; Kovacevic Z; V Menezes S; Kalinowski DS; Merlot AM; Sahni S; Richardson DR
    Mol Pharmacol; 2015; 87(3):543-60. PubMed ID: 25561562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.